- Home
- KRRO vs EDD Comparison
KRRO vs EDD Comparison
Compare KRRO & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- EDD
- Stock Information
- Founded
- KRRO 2014
- EDD 2007
- Country
- KRRO United States
- EDD United States
- Employees
- KRRO N/A
- EDD N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- KRRO Health Care
- EDD Finance
- Exchange
- KRRO Nasdaq
- EDD Nasdaq
- Market Cap
- KRRO 281.2M
- EDD 307.8M
- IPO Year
- KRRO 2019
- EDD N/A
- Fundamental
- Price
- KRRO $26.29
- EDD $4.82
- Analyst Decision
- KRRO Strong Buy
- EDD
- Analyst Count
- KRRO 7
- EDD 0
- Target Price
- KRRO $133.83
- EDD N/A
- AVG Volume (30 Days)
- KRRO 61.9K
- EDD 254.3K
- Earning Date
- KRRO 03-25-2025
- EDD 01-01-0001
- Dividend Yield
- KRRO N/A
- EDD 7.52%
- EPS Growth
- KRRO N/A
- EDD N/A
- EPS
- KRRO N/A
- EDD N/A
- Revenue
- KRRO N/A
- EDD N/A
- Revenue This Year
- KRRO N/A
- EDD N/A
- Revenue Next Year
- KRRO N/A
- EDD N/A
- P/E Ratio
- KRRO N/A
- EDD N/A
- Revenue Growth
- KRRO N/A
- EDD N/A
- 52 Week Low
- KRRO $26.23
- EDD $4.22
- 52 Week High
- KRRO $98.00
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- KRRO 29.17
- EDD 65.82
- Support Level
- KRRO $28.90
- EDD $4.68
- Resistance Level
- KRRO $40.68
- EDD $4.82
- Average True Range (ATR)
- KRRO 2.26
- EDD 0.06
- MACD
- KRRO -0.36
- EDD 0.00
- Stochastic Oscillator
- KRRO 0.42
- EDD 95.17
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.